President Donald Trump is expected to sign an executive order soon to lower the cost of prescription drugs for Medicare ...

Jardiance is a medication doctors prescribe to treat heart failure and type 2 diabetes. Most Medicare Part D prescription drug plans include coverage for Jardiance. Part C plans with drug coverage ...

One drug in particular, Jardiance, had the largest price disparity, where in New York, NY, for 90, 10mg tablets, the drug’s price was $1,888.75, while TotalCareMart.com’s price was $239.99. Although ...

Post patent expiry, numerous Indian companies launched generic versions of Empagliflozin. The market witnessed a surge in ...

Eli Lilly misses first-quarter estimates for earnings but beats the same for sales. Mounjaro and Zepbound sales beat ...

Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first-quarter of 2025.

In 2025, health means staying alive from the inside. Taking advantage of the bedeviled blessing of insurance, scheduling ...

Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has been approved for chronic kidney disease in the EU - the first major market to clear the new use for the drug. Adding CKD to the ...

AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the amount of Medicare spending subject to price negotiation by billions of ...

The EMPACT-MI trial found that giving Boehringer Ingelheim and Eli Lilly’s SGLT2 drug Jardiance (empagliflozin) within 14 days of an acute myocardial infarction (AMI) reduced the risk of a ...

To say, as CEO David Ricks did, that this was a good quarter, is an understatement. Mounjaro in diabetes brought in $3.84 ...